We’re excited to collaborate with the National Cancer Institute (NCI) on the myeloMATCH umbrella trial in an effort to help advance research in precision oncology. This groundbreaking program will fast-track acute myeloid leukemia patient enrollment in clinical trials informed by genomic insights provided by our next-day, sequencing technology. Accelerating this research provides hope for a future in which patients will have access to the right therapies based on their genomic profile and transform their cancer treatment journey. https://bit.ly/4f1iACO
Hello I was intrigued by the myelomatch study which has been initiated by The NCI. In india we have so many AML patients and the concept of NGS is elusive. I request to give us access to the study so as to broaden the outreach. Im sure the essence of the study is to make sure all AML s are sequenced and offered genetically inspired therapy. Please help
Having worked closely with childhood cancer for 22 years and watching families torn apart by cancer, I’m continually amazed at the advancements in cancer. I’m equally thrilled and proud to work for a company that is truly making an incredible impact. Kudos to all those involved!
Proud of this advancement and of the entire team who made it happen!!
We lost my sister, Peggy, to a lengthy battle with AML in 2011, so it's exciting to read about these promising advancements in cancer care. Thank you to the Thermo Fisher Scientific team for all the work and dedication!
So proud to be supporting this team at Thermo Fisher Scientific, way to go!
Such an important advancement in cancer care!
Way to go team!
Important advancement in Cancer Care
Ml
Product Manager at Thermo Fisher Scientific
1moMoving forward with promise of quick turn around time!